Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > What is the Cure for Cancer worth
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(186)
•••
Comment by robertshawon Apr 15, 2021 4:52pm
122 Views
Post# 33005295

RE:RE:RE:RE:What is the Cure for Cancer worth

RE:RE:RE:RE:What is the Cure for Cancer worth
patience69 wrote: Skys 
Thanks for your interesting summary. I agree & your ideas make a lot of sense to me. The only part I dont understand which apparently you do is the year delay. Why a year delay? Why announce it now?


According to skys'post( reading between lines of the NR of Li Ka Shing Knowledge Institute co-op, by announcing it now 1 year ahead of the time, RDW tries to tell all of Blowjobjoe's bosses indirectly, he has no interests to play dirty cheap PP games with them(Blowjobjoe's bosses)... As Li Ka Shing Knowledge Institute might offer far more better PP (or that kind of financial aid) to TLD1433 one year after now, Probably $30 +/share with 5 years warranties of $35/unit.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities